Unlock instant, AI-driven research and patent intelligence for your innovation.

sva-pcv2 fusion protein and its preparation method, gene, biological material, application and vaccine

A 1. SVA-PCV2, fusion protein technology, applied in the biological field, can solve the problems of infection, economic loss in aquaculture, and achieve the effect of strong antigenicity

Active Publication Date: 2021-04-13
天康生物制药有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And PCV2 is a kind of immunosuppressive piglets, a viral infectious disease that highly infects pigs, can cause pigs of all ages to be infected, and cause huge economic losses to the breeding industry

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • sva-pcv2 fusion protein and its preparation method, gene, biological material, application and vaccine
  • sva-pcv2 fusion protein and its preparation method, gene, biological material, application and vaccine
  • sva-pcv2 fusion protein and its preparation method, gene, biological material, application and vaccine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0061] The present invention also provides a method for preparing the above-mentioned SVA-PCV2 fusion protein. The preparation method includes: expressing the gene encoding the SVA-PCV2 fusion protein in a host; system, insect expression system, plant expression system or mammalian expression system, preferably expressed in CHO-S cells.

[0062] In some preferred embodiments, the SVA-PCV2 fusion protein is prepared as follows:

[0063] (a) The VP1 polypeptide of SVA is connected to the PCV2Cap protein through flexible amino acids, and the gene encoding the fusion protein is artificially synthesized after optimization of partial tropism codons.

[0064] (b) The artificially synthesized gene was inserted into the eukaryotic expression vector pcDNATM3.1-TOPO, identified by restriction enzyme digestion and sequenced, and a positive recombinant vector was screened out to obtain the pcDNA3.1-SVA-PCV2-Cap plasmid.

[0065] (c) pcDNA3.1-SVA-PCV2-Cap plasmid using FreeStyle TM MAX R...

Embodiment 1

[0078] According to the SVA and PCV2 genomes obtained by logging into GenBank, the candidate gene sequences were finally determined through sequence comparison analysis. The polypeptide gene sequence of SVAVP1 was derived from GenBank: KY747519.1, and the gene sequence of PCV2Cap protein was derived from GenBank: FJ158606.

[0079] In this embodiment, two polypeptide genes of SVAVP1 are used, one is named SVA3, and the coding sequence of SVA3 is shown in SEQ ID NO.1; the other is named SVA5, and the coding sequence of SVA5 is shown in SEQ ID NO.2. Connect SVA3 and SVA5 to the PCV2Cap protein gene sequence end-to-end through the coding sequence of the connecting peptide, wherein the PCV2Cap protein gene sequence is shown in SEQ ID NO.3, and the coding sequence of the connecting peptide is shown in SEQ ID NO.4. After optimization of the tropism codon, restriction sites HindIII and BamHI were inserted at both ends of the gene, and sent to a synthetic company for gene synthesis to ...

Embodiment 2

[0081] To construct the pcDNA3.1-SVA-PCV2-Cap vector, the construction steps are as follows:

[0082] (a) Ligation: The recovered PCR product was ligated with pcDNA3.1. The ligation system (10 μL / tube) was as follows: 1 μL of pcDNA3.1 vector, 2 μL of recovered enzyme digestion product, dH 2 O 2 μL, Solution I 5 μL, and connect overnight on the connection instrument at 16°C.

[0083] (b) Preparation of Escherichia coli competent cells: a single colony was picked from a petri dish and inoculated into a test tube containing 10 mL of LB liquid medium, and cultivated overnight at 37°C. Take 100 μL of the bacterial solution and transfer it to a centrifuge tube containing 10 mL of liquid LB medium, incubate with shaking at 37°C for 2 hours; divide the bacterial solution into 1.5mL centrifuge tubes, and place in an ice bath for 20 minutes; centrifuge at 4,000 rpm for 5 minutes at 4°C, discard the supernatant ; Add 1 / 5 volume (200 μL) of pre-cooled CaCl 2 Buffer, gently suspend the c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a SVA-PCV2 fusion protein and its preparation method, gene, biological material, application and vaccine, and relates to the field of biotechnology. The SVA‑PCV2 fusion protein consists of an SVA segment and a PCV2 segment, wherein the SVA segment contains the VP1 polypeptide of SVA, and the PCV2 segment contains the Cap protein of PCV2. The SVA-PCV2 fusion protein has both the immunogenicity of SVA and PCV2, and can make the body generate immune responses to SVA and PCV2 at the same time. Based on the above inventive concept, the present invention also provides genes mainly encoding SVA-PCV2 fusion proteins, including their biological materials and vaccines, wherein the vaccine provided by the present invention has dual immunogenicity of SVA and PCV2, and can achieve one-shot prevention of two disease purpose.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a SVA-PCV2 fusion protein and its preparation method, gene, biological material, application and vaccine. Background technique [0002] Seneca valley virus A (SVA) belongs to the Picornaviridae family, Seneca valley virus genus, Seneca valley virus A species, the genome is single-stranded positive-strand RNA, composed of about 7200 nucleotides , encoding 4 structural proteins and 7 non-structural proteins, and the virion has a typical icosahedral symmetry. [0003] Porcine circovirus (Porcine Circovirus, PCV) belongs to the family Circoviridae. Its genome is a single-stranded circular DNA. The virion has no envelope and is icosahedral. PCV has two genotypes, type I and type II. PCV1 was first discovered by Tischer in PK-15 cells, with a genome length of 1759bp and no pathogenicity; PCV2 genome length is 1767bp or 1768bp, and the genome encodes structural proteins Cap protein and Pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/85C12N5/10A61K39/295A61K39/12A61K39/125A61P31/14A61P31/20
CPCA61K39/12A61K2039/552A61K2039/70A61P31/14A61P31/20C07K14/005C12N15/85C12N2750/10022C12N2750/10034C12N2770/32022C12N2770/32034
Inventor 贺笋高窦李俊辉张伟程兰玲
Owner 天康生物制药有限公司